Biogen Inc. (BIIB) NASDAQ
191.91
-1.04(-0.54%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
191.91
-1.04(-0.54%)
Currency In USD
| Market Cap | 25.82B |
| Enterprise Value | 29.76B |
| P/E Ratio | 20.58 |
| PEG Ratio | -2.65 |
| Price/Sales Ratio | 2.87 |
| Price/Book Ratio | 1.51 |
| Enterprise/Revenue | 3.2 |
| Enterprise/EBITDA | 11.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.14 |
| Operating Margin | 0.16 |
| Return On Assets | 0.05 |
| Return On Equity | 0.08 |
| Revenue | 9.81B |
| Revenue/Share | 66.97 |
| Gross Profit | 6.91B |
| EBITDA | 3.1B |
| Net Income | 1.29B |
| Diluted EPS | 8.83 |
| Total Cash | 4.28B |
| Total Cash/Share | 29.09 |
| Total Debt | 6.56B |
| Total Debt/Equity | 0.35 |
| Current Ratio | 3.06 |
| Book Value Per Share | 126.71 |
| 52-Week Change | 48.26 |
| 52-Week High | 205.97 |
| 52-Week Low | 121.05 |
| Moving Average 50 Days | 185.39 |
| Moving Average 200 Days | 167.72 |
| Average Volume | 1.14M |
| Shares Outstanding | 147.64M |
| % Held by Institutions | 90 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
| Last Split Date | January 18, 2001 |